TL;DR
Overall, TRK61 shows strong lytic activity and in vivo efficacy, supporting its potential as a therapeutic or biocontrol agent against MDR Klebsiella.
It is suggested that vB_Kp_H122 may have potential as an antibacterial candidate against K57 MDR‐hvKP isolates, a novel lytic phage that specifically targets K57 capsular‐type MDR‐hvKP.
ABSTRACT The emergence of multidrug-resistant Klebsiella pneumoniae (KPN) and antibiotic-tolerant persister cells poses a significant challenge to existing anti-infection therapies. Given the urgent need for sustainable alternatives to antibiotics, phage cocktails are emerging as a promising alternative to control K. p...
The rapid growth of global aquaculture has led to a rise in bacterial diseases, threatening food security and economies in developing countries. Vibriosis, caused by Vibrio bacteria, is the most common and devastating disease in shrimp farming, a crisis severely exacerbated by the emergence of multidrug-resistant p...
The alarming rates at which extensively drug-resistant (XDR) and pandrug-resistant (PDR) Enterobacter cloacae in hospitals are increasing has begun to severely limit treatment options, and thus the urgency for alternative interventions, including bacteriophage therapy. The purpose of the study was to isolate and molecu...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
